
A US district judge has reversed a previous court decision which favoured MSD, called Merck in the US, over Gilead …

Prostate cancer treatment Jevtana (cabazitaxel), marketed by Sanofi (NYSE: SNY) has been recommended by NICE in its final guidance. The …

